Dr. Aubrey de Grey of SENS Research Foundation gave the keynote speech at Ending Age-Related Diseases 2020. Aubrey discussed the current state of the rejuvenation biotechnology industry and how the current pandemic is shifting medical and science priorities. He mentions the failure of Unity Biotechnology's Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology and developments to a world without age-related diseases.
There is now funding for the detailed work to define an Aging reversal XPrize focused on rejuvenating the immune system. The detailed definition of an XPrize requires nearly $1 million. Michael Antonov and Sergey Young have provided the funding.